SG11202106114XA - Cell-free dna end characteristics - Google Patents
Cell-free dna end characteristicsInfo
- Publication number
- SG11202106114XA SG11202106114XA SG11202106114XA SG11202106114XA SG11202106114XA SG 11202106114X A SG11202106114X A SG 11202106114XA SG 11202106114X A SG11202106114X A SG 11202106114XA SG 11202106114X A SG11202106114X A SG 11202106114XA SG 11202106114X A SG11202106114X A SG 11202106114XA
- Authority
- SG
- Singapore
- Prior art keywords
- cell
- free dna
- dna end
- end characteristics
- free
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/38—Pediatrics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7042—Aging, e.g. cellular aging
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Artificial Intelligence (AREA)
- Evolutionary Computation (AREA)
- Software Systems (AREA)
- Bioethics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Biomedical Technology (AREA)
- Primary Health Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862782316P | 2018-12-19 | 2018-12-19 | |
PCT/CN2019/126565 WO2020125709A1 (en) | 2018-12-19 | 2019-12-19 | Cell-free dna end characteristics |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202106114XA true SG11202106114XA (en) | 2021-07-29 |
Family
ID=71099178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202106114XA SG11202106114XA (en) | 2018-12-19 | 2019-12-19 | Cell-free dna end characteristics |
Country Status (11)
Country | Link |
---|---|
US (1) | US20200199656A1 (en) |
EP (2) | EP4300500A3 (en) |
JP (1) | JP2022514879A (en) |
KR (1) | KR20210113237A (en) |
CN (2) | CN117778576A (en) |
AU (1) | AU2019410635A1 (en) |
CA (1) | CA3123474A1 (en) |
DK (1) | DK3899018T3 (en) |
SG (1) | SG11202106114XA (en) |
TW (1) | TW202039860A (en) |
WO (1) | WO2020125709A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI803477B (en) * | 2017-01-25 | 2023-06-01 | 香港中文大學 | Diagnostic applications using nucleic acid fragments |
CA3162089A1 (en) * | 2020-01-08 | 2021-07-15 | Yuk-Ming Dennis Lo | Biterminal dna fragment types in cell-free samples and uses thereof |
JP2023540016A (en) * | 2020-08-19 | 2023-09-21 | アキュラーゲン ホールディングス リミテッド | Method for selective cell-free nucleic acid analysis |
CA3205119A1 (en) * | 2020-12-15 | 2022-06-23 | Gateway Genomics, Llc | Methods, compositions, and devices for the rapid determination of fetal sex |
KR20220160806A (en) | 2021-05-28 | 2022-12-06 | 주식회사 지씨지놈 | Method for diagnosing and predicting cancer type using fragment end motif frequency and size of cell-free nucleic acid |
KR20230064172A (en) * | 2021-11-03 | 2023-05-10 | 주식회사 지씨지놈 | Method for detecting cancer using fragment end sequence frequency and size by position of cell-free nucleic acid |
US20230279498A1 (en) * | 2021-11-24 | 2023-09-07 | Centre For Novostics Limited | Molecular analyses using long cell-free dna molecules for disease classification |
US20240011105A1 (en) * | 2022-07-08 | 2024-01-11 | The Chinese University Of Hong Kong | Analysis of microbial fragments in plasma |
CN114898802B (en) * | 2022-07-14 | 2022-09-30 | 臻和(北京)生物科技有限公司 | Terminal sequence frequency distribution characteristic determination method, evaluation method and device based on plasma free DNA methylation sequencing data |
US20240043935A1 (en) * | 2022-07-29 | 2024-02-08 | Centre For Novostics Limited | Epigenetics analysis of cell-free dna |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105243295B (en) | 2010-11-30 | 2018-08-17 | 香港中文大学 | With the relevant heredity of cancer or the detection of molecular distortion |
US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
US11261494B2 (en) | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
NZ706269A (en) * | 2012-09-20 | 2016-08-26 | Univ Hong Kong Chinese | Non-invasive determination of methylome of fetus or tumor from plasma |
US9732390B2 (en) | 2012-09-20 | 2017-08-15 | The Chinese University Of Hong Kong | Non-invasive determination of methylome of fetus or tumor from plasma |
PT3543356T (en) * | 2014-07-18 | 2021-10-04 | Univ Hong Kong Chinese | Methylation pattern analysis of tissues in dna mixture |
EP4358097A1 (en) * | 2014-07-25 | 2024-04-24 | University of Washington | Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same |
US11242559B2 (en) * | 2015-01-13 | 2022-02-08 | The Chinese University Of Hong Kong | Method of nuclear DNA and mitochondrial DNA analysis |
PT3256605T (en) * | 2015-02-10 | 2022-03-17 | Univ Hong Kong Chinese | Detecting mutations for cancer screening and fetal analysis |
IL305462A (en) * | 2015-07-23 | 2023-10-01 | Univ Hong Kong Chinese | Analysis of fragmentation patterns of cell-free dna |
WO2018009723A1 (en) * | 2016-07-06 | 2018-01-11 | Guardant Health, Inc. | Methods for fragmentome profiling of cell-free nucleic acids |
EP3535415A4 (en) * | 2016-10-24 | 2020-07-01 | The Chinese University of Hong Kong | Methods and systems for tumor detection |
CN109983134A (en) * | 2016-11-30 | 2019-07-05 | 香港中文大学 | The analysis of Cell-free DNA in urine and other samples |
WO2019210873A1 (en) | 2018-05-03 | 2019-11-07 | The Chinese University Of Hong Kong | Size-tagged preferred ends and orientation-aware analysis for measuring properties of cell-free mixtures |
-
2019
- 2019-12-19 WO PCT/CN2019/126565 patent/WO2020125709A1/en unknown
- 2019-12-19 CA CA3123474A patent/CA3123474A1/en active Pending
- 2019-12-19 SG SG11202106114XA patent/SG11202106114XA/en unknown
- 2019-12-19 TW TW108146736A patent/TW202039860A/en unknown
- 2019-12-19 US US16/721,619 patent/US20200199656A1/en active Pending
- 2019-12-19 EP EP23205094.8A patent/EP4300500A3/en active Pending
- 2019-12-19 AU AU2019410635A patent/AU2019410635A1/en active Pending
- 2019-12-19 EP EP19898588.9A patent/EP3899018B1/en active Active
- 2019-12-19 KR KR1020217022713A patent/KR20210113237A/en unknown
- 2019-12-19 DK DK19898588.9T patent/DK3899018T3/en active
- 2019-12-19 CN CN202311817532.XA patent/CN117778576A/en active Pending
- 2019-12-19 JP JP2021535750A patent/JP2022514879A/en active Pending
- 2019-12-19 CN CN201980091039.XA patent/CN113366122B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN113366122A (en) | 2021-09-07 |
EP4300500A3 (en) | 2024-03-27 |
CA3123474A1 (en) | 2020-06-25 |
CN117778576A (en) | 2024-03-29 |
DK3899018T3 (en) | 2024-01-08 |
EP3899018A4 (en) | 2022-09-14 |
AU2019410635A1 (en) | 2021-06-17 |
KR20210113237A (en) | 2021-09-15 |
EP3899018B1 (en) | 2023-12-06 |
WO2020125709A1 (en) | 2020-06-25 |
CN113366122B (en) | 2024-01-12 |
US20200199656A1 (en) | 2020-06-25 |
TW202039860A (en) | 2020-11-01 |
EP3899018A1 (en) | 2021-10-27 |
JP2022514879A (en) | 2022-02-16 |
EP4300500A2 (en) | 2024-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11202106114XA (en) | Cell-free dna end characteristics | |
DK3793565T3 (en) | Mcl-1-inhibitorer | |
IL274442A (en) | Rna sequence adaptation | |
DK3467457T3 (en) | Vibrationssensor | |
DK3759096T3 (en) | Cd73-inhibitorer | |
CA185382S (en) | Casque | |
CA185384S (en) | Casque | |
SG11202009192PA (en) | Nano-satellite | |
CA185385S (en) | Casque | |
DK3773537T3 (en) | Stat3-hæmmere | |
DK3554057T3 (en) | Audioheadsetsystem | |
DK3613739T3 (en) | Integrin-antagonister | |
CA184991S (en) | Uroflowmeter | |
DK3872428T3 (en) | Indvendigt luftstyringssystem | |
CA184992S (en) | Uroflowmeter | |
GB201806174D0 (en) | Improved downlighter | |
HUE064581T2 (en) | End effectors | |
EP3766087C0 (en) | Sensformer | |
GB201805799D0 (en) | b | |
DK3674425T3 (en) | Stålwire | |
CA187782S (en) | Pompon-maker | |
DK3542617T3 (en) | Etikette | |
CA185267S (en) | Corkscrew | |
EP3784424C0 (en) | Millstand | |
GB201901706D0 (en) | b |